• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Yamamoto Tomofumi  山元 智史

ORCIDConnect your ORCID iD *help
Researcher Number 40963369
Other IDs
Affiliation (Current) 2025: 国立医薬品食品衛生研究所, 生物薬品部, 研究員
2025: 東京医科大学, 医学部, 客員研究員
Affiliation (based on the past Project Information) *help 2024: 東京医科大学, 医学部, 助教(特任)
2023 – 2024: 国立医薬品食品衛生研究所, 生物薬品部, 任期付研究員
2022: 東京医科大学, 医学部, 助教(特任)
Review Section/Research Field
Principal Investigator
Basic Section 47060:Clinical pharmacy-related / 0901:Oncology and related fields
Except Principal Investigator
Basic Section 56030:Urology-related / Basic Section 55010:General surgery and pediatric surgery-related
Keywords
Principal Investigator
エクソソーム / 細胞外小胞 / 間葉系幹細胞 / レナリドミド / 薬剤耐性 / 多発性骨髄腫
Except Principal Investigator
細胞外小胞 / 去勢抵抗性前立腺癌 / 免疫増強薬 / リキッドバイオプシー / 脂質代謝 / 乳癌
  • Research Projects

    (4 results)
  • Research Products

    (3 results)
  • Co-Researchers

    (3 People)
  •  Liquid Biopsy for Breast Cancer Focusing on Lipids in Extracellular Vesicles

    • Principal Investigator
      川島 雅央
    • Project Period (FY)
      2024 – 2026
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Review Section
      Basic Section 55010:General surgery and pediatric surgery-related
    • Research Institution
      Kyoto University
  •  去勢抵抗性前立腺癌に対する細胞外小胞スクリーニング法を用いた新規免疫増強薬の探索

    • Principal Investigator
      松下 麻衣子
    • Project Period (FY)
      2024 – 2026
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 56030:Urology-related
    • Research Institution
      Keio University
  •  医療応用可能なエクソソームの大量産生系と評価方法の確立Principal Investigator

    • Principal Investigator
      山元 智史
    • Project Period (FY)
      2024 – 2025
    • Research Category
      Grant-in-Aid for Early-Career Scientists
    • Review Section
      Basic Section 47060:Clinical pharmacy-related
    • Research Institution
      National Institute of Health Sciences
  •  Understanding of multiple myeloma IMiDs resistance via extracellular vesiclesPrincipal Investigator

    • Principal Investigator
      Yamamoto Tomofumi
    • Project Period (FY)
      2022 – 2023
    • Research Category
      Grant-in-Aid for Research Activity Start-up
    • Review Section
      0901:Oncology and related fields
    • Research Institution
      National Institute of Health Sciences
      Tokyo Medical University

All 2024 2023

All Journal Article Presentation

  • [Journal Article] Extracellular vesicle-mediated drug resistance in multiple myeloma2023

    • Author(s)
      Tomofumi Yamamoto, Yusuke Yamamoto
    • Journal Title

      Rinsho Ketsueki

      Volume: 64 Issue: 9 Pages: 1092-1098

    • DOI

      10.11406/rinketsu.64.1092

    • ISSN
      0485-1439, 1882-0824
    • Language
      Japanese
    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22K20803
  • [Presentation] 薬剤耐性骨髄腫細胞由来の細胞外小胞が内包するmicroRNAとIMiDs耐性化機構との関連性の検討2024

    • Author(s)
      山元 智史
    • Organizer
      日本骨髄腫学会
    • Data Source
      KAKENHI-PROJECT-22K20803
  • [Presentation] 多発性骨髄腫におけるレナリドミド耐性と細胞外小胞分泌2023

    • Author(s)
      山元 智史
    • Organizer
      日本がん分子標的治療学会学術集会
    • Data Source
      KAKENHI-PROJECT-22K20803
  • 1.  川島 雅央 (80766676)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 2.  杉本 昌弘 (30458963)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 3.  松下 麻衣子 (10327520)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi